Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community
暂无分享,去创建一个
M. R. Oliva | G. Sáez | P. Muñiz | V. Valls | R. Trullenque | E. Drehmer | A. Iradi | Francisco Ripoll
[1] C. Cordon-Cardo,et al. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP. , 1995, Diagnostic molecular pathology (Print).
[2] D. Phillips,et al. Induction of activating mutations in the human c‐Ha‐ras‐1 proto‐oncogene by oxygen free radicals , 1994, Molecular carcinogenesis.
[3] C. Cordon-Cardo,et al. Altered patterns of MDM2 and TP53 expression in human bladder cancer. , 1994, Journal of the National Cancer Institute.
[4] D. S. St. Clair,et al. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. , 1994, Cancer research.
[5] P. Cerutti,et al. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. , 1994, Oncogene.
[6] J. Willson,et al. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. , 1994, Cancer research.
[7] Z. F. Liu,et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.
[8] C. Harris,et al. Geographic variation of p53 mutational profile in nonmalignant human liver. , 1994, Science.
[9] A. Fornace,et al. The p53-dependent γ-Ray Response of GADD45 , 1994 .
[10] M. Fukayama,et al. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential , 1994, Cancer.
[11] C. Cordon-Cardo,et al. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns , 1994, International journal of cancer.
[12] A. Levine,et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. , 1994, Cancer research.
[13] R. Mangues,et al. Absence of MDM‐2 gene amplification in experimentally induced tumors regardless of p53 status , 1994, Molecular carcinogenesis.
[14] H. Kovar,et al. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. , 1993, Oncogene.
[15] T. Sellers,et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. , 1993, Cancer research.
[16] A. Levine,et al. Mapping of the p53 and mdm-2 interaction domains. , 1993, Molecular and cellular biology.
[17] S. Hamilton,et al. The molecular genetics of colorectal neoplasia. , 1993, Gastroenterology.
[18] P. Meltzer,et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. , 1993, Cancer research.
[19] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[20] J. Marx. New colon cancer gene discovered. , 1993, Science.
[21] C. Boland,et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. , 1993, Gastroenterology.
[22] R. Lothe,et al. The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. , 1993, British Journal of Cancer.
[23] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[24] M. Kastan,et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Levine,et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[27] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[28] K. Frenkel,et al. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: a possible mechanism of antipromotion. , 1992, Cancer research.
[29] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[30] R. Metcalf,et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. , 1991, Cancer research.
[31] J. Solomon,et al. Quantitative high-performance liquid chromatography analysis of DNA oxidized in vitro and in vivo. , 1991, Analytical biochemistry.
[32] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[33] D. George,et al. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. , 1991, The EMBO journal.
[34] J. Wands,et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.
[35] A. Grollman,et al. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG , 1991, Nature.
[36] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[37] J. Bufill,et al. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. , 1990, Annals of internal medicine.
[38] R. Floyd. The role of 8-hydroxyguanine in carcinogenesis. , 1990, Carcinogenesis.
[39] J. Essigmann,et al. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. , 1990, Biochemistry.
[40] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[41] E. Stanbridge. Identifying tumor suppressor genes in human colorectal cancer. , 1990, Science.
[42] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[43] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[44] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[45] R. Weinberg,et al. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.
[46] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[47] M. Leppert,et al. Allelic Loss in Colorectal Carcinoma , 1989 .
[48] Y. Nakamura,et al. Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. , 1989, JAMA.
[49] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[50] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[51] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Floyd,et al. Hydroxyl free radical mediated formation of 8-hydroxyguanine in isolated DNA. , 1988, Archives of biochemistry and biophysics.
[53] K. Sugio,et al. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli , 1988, Nature.
[54] B. Ames,et al. Oxygen radicals and human disease. , 1987, Annals of internal medicine.
[55] H. Kasai,et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues , 1987, Nature.
[56] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[57] P. Cerutti. Prooxidant states and tumor promotion. , 1985, Science.
[58] H. Sies,et al. Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. , 1983, Biochemical pharmacology.
[59] M. Uchiyama,et al. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. , 1978, Analytical biochemistry.
[60] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[62] G. Thomas,et al. Association of p53 mutations with short survival in colorectal cancer. , 1994, Gastroenterology.
[63] K. Guyton,et al. Oxidative mechanisms in carcinogenesis. , 1993, British medical bulletin.
[64] J. Gutteridge,et al. Free radicals in disease processes: a compilation of cause and consequence. , 1993, Free radical research communications.
[65] K. Frenkel. Carcinogen-mediated oxidant formation and oxidative DNA damage. , 1992, Pharmacology & therapeutics.
[66] A. Fornace. Mammalian genes induced by radiation; activation of genes associated with growth control. , 1992, Annual review of genetics.
[67] Y. Sun,et al. Free radicals, antioxidant enzymes, and carcinogenesis. , 1990, Free radical biology & medicine.